Ginkgo Bioworks DNA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's investing cash flow?
- Ginkgo Bioworks (DNA) reported investing cash flow of $23.13M in Q1 2026.
- How has Ginkgo Bioworks's investing cash flow changed year-over-year?
- Ginkgo Bioworks's investing cash flow increased by 111.6% year-over-year, from -$198.68M to $23.13M.
- What is the long-term trend for Ginkgo Bioworks's investing cash flow?
- Over 2 years (2021 to 2024), Ginkgo Bioworks's investing cash flow has grown at a -10.4% compound annual growth rate (CAGR), from -$77.49M to -$62.24M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.